Sally C. Pipes
Commentary
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Sally C. Pipes
July 20, 2020
Commentary
Medicaid Expansion Will Add To Oklahoma’s Woes
Late last month, Oklahoma voters narrowly approved a ballot measure expanding the state’s Medicaid program to childless adults making up to 138% of the poverty level under the terms of Obamacare. Missouri could follow suit next month when a similar ballot initiative comes up for a vote. Medicaid expansion seems ...
Sally C. Pipes
July 20, 2020
Commentary
Sally C. Pipes Talks COVID-19, State Closures on the Larry Elder Show
Possibility of huge tax increases, discrepancies with COVID-19 numbers and the overall impact of 80 percent of, 45 percent of people who have died were in nursing homes, and only 3 percent is 25 to 44-years-old. Elder and Pipes also talk about the transmission rates among children, the announcement that ...
Sally C. Pipes
July 14, 2020
Coronavirus
Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is ...
Sally C. Pipes
July 14, 2020
Commentary
We know how to safely reopen the country
More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and ...
Sally C. Pipes
July 14, 2020
Commentary
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Sally C. Pipes
July 13, 2020
Commentary
Dems Want to Use Medicaid to Incinerate Yet More Taxpayer Money
Congressional Democrats are looking to put billions more federal dollars into Medicaid as part of their plan to fight COVID-19. The HEROES Act, which narrowly passed the House in May, would temporarily increase the share of the program’s spending covered by the federal government, to the tune of $45 billion ...
Sally C. Pipes
July 12, 2020
Commentary
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Sally C. Pipes
July 12, 2020
Health Care
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Sally C. Pipes
July 9, 2020
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Sally C. Pipes
July 6, 2020
Biden a moderate? Sanders, AOC plans for candidate suggest this instead
Presumptive Democratic presidential nominee Joe Biden has long been considered a political moderate. A new report from his “unity” task forces should put that reputation to rest. The 110-page document offers detailed policy recommendations for an incoming Biden administration. It would represent the most left-wing governing program of any president ...
Medicaid Expansion Will Add To Oklahoma’s Woes
Late last month, Oklahoma voters narrowly approved a ballot measure expanding the state’s Medicaid program to childless adults making up to 138% of the poverty level under the terms of Obamacare. Missouri could follow suit next month when a similar ballot initiative comes up for a vote. Medicaid expansion seems ...
Sally C. Pipes Talks COVID-19, State Closures on the Larry Elder Show
Possibility of huge tax increases, discrepancies with COVID-19 numbers and the overall impact of 80 percent of, 45 percent of people who have died were in nursing homes, and only 3 percent is 25 to 44-years-old. Elder and Pipes also talk about the transmission rates among children, the announcement that ...
Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is ...
We know how to safely reopen the country
More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and ...
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Dems Want to Use Medicaid to Incinerate Yet More Taxpayer Money
Congressional Democrats are looking to put billions more federal dollars into Medicaid as part of their plan to fight COVID-19. The HEROES Act, which narrowly passed the House in May, would temporarily increase the share of the program’s spending covered by the federal government, to the tune of $45 billion ...
Expand Medicaid? Democrats’ plan would increase waste, fraud and debt
If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Sally C. Pipes Discuss Obamacare Supreme Court Hearing on the Kim Monson Show
Sally C. Pipes joined the Kim Monson Show to discusses the pending U.S. Supreme Court hearing for Obamacare. Pipes explains that we are still a year or more way from a final decision, with hearings scheduled for the fall and a final decision expected 2021. Pipes and Monson also discuss ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...